A Prospective, Randomised, Placebo Controlled, Double Blind Trial About Safety and Efficacy of Combined Treatment With Alteplase (rt-PA) and Cerebrolysin in Acute Ischaemic Hemispheric Stroke.
Latest Information Update: 19 Jan 2022
At a glance
- Drugs Alteplase (Primary) ; FPF 1070 (Primary)
- Indications Embolism and thrombosis; Stroke
- Focus Therapeutic Use
- Acronyms CERE-LYSE-1
- 19 Jan 2022 This trial has been completed in Slovakia, according to European Clinical Trials Database record.
- 14 Feb 2009 New trial record